Localization of proteins in the cell wall of Mycobacterium avium subsp. paratuberculosis K10 by proteomic analysis

Zhiguo He1, Jeroen De Buck

  • 1Department of Production Animal Health, Faculty of Veterinary Medicine, University of Calgary, 3330 Hospital Drive NW, Calgary, AB T2N 4N1, Canada. jdebuck@ucalgary.ca.

Proteome Science
|April 10, 2010
PubMed

Insights

Mycobacterium avium subsp. paratuberculosis (MAP) cell wall proteins were identified using proteomics. This study characterized MAP

Area of Science:

  • Microbiology
  • Proteomics
  • Bioinformatics

Background:

  • Mycobacterium avium subsp. paratuberculosis (MAP) causes Johne's disease, a chronic enteritis in ruminants.
  • Mechanisms of MAP persistence and Johne's disease development are poorly understood.
  • Understanding MAP's cell wall and surface proteins is crucial for disease control.

Purpose of the Study:

  • To identify and characterize cell wall-associated and surface-exposed proteins of Mycobacterium avium subsp. paratuberculosis K10.
  • To create a comprehensive proteomic profile of the MAP K10 cell wall subproteome.
  • To provide a foundation for developing new strategies against MAP infections.

Main Methods:

  • Proteomic analysis using one-dimensional polyacrylamide gel electrophoresis (SDS-PAGE) and LC-MS/MS.
  • Cell surface enzymatic shaving with trypsin treatment to identify surface-exposed proteins.
  • Bioinformatic approaches for categorization and analysis of identified proteins.

Main Results:

  • 309 different cell wall-associated proteins were identified in MAP K10.
  • 101 identified proteins were previously annotated as hypothetical or conserved hypothetical.
  • 38 proteins were determined to be surface-exposed, with 18 shared between the cell wall and surface proteomes.

Conclusions:

  • A comprehensive proteomic profile of the MAP K10 cell wall subproteome was established.
  • This proteomic data provides insights into MAP's cellular structure and potential virulence factors.
  • The findings can inform the development of novel preventive, diagnostic, and therapeutic strategies for MAP infections.

Related Concept Videos